MYGALAXY LTD COMPANY has a total of 21 patent applications. Its first patent ever was published in 2012. It filed its patents most often in China, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SHANGHAI BIOASIA LIFE TECHNOLOGY CO LTD, Hansa Biopharma AB and SHROFF GEETA.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Argentina | 1 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | Chile | 1 | |
#10 | Colombia | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Mexico | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Jiang Yiwei | 19 |
#2 | Yiwei Jiang | 2 |
Publication | Filing date | Title |
---|---|---|
CN104780931A | Uses of bt lipopeptides as therapeutics for obesity and related diseases | |
CN105567587A | Sporulation-deficient b. Texasporus cells and methods for efficient and cost-effective inactivation and use thereof |